Normative data for the Nasal Obstruction Symptom Evaluation Scale in the general Australian population.
cosmetic technique
nasal obstruction
otolaryngology head and neck surgery
plastic and reconstructive surgery
population health
quality of life
rhinoplasty
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
25
02
2020
accepted:
20
04
2020
pubmed:
19
5
2020
medline:
15
5
2021
entrez:
19
5
2020
Statut:
ppublish
Résumé
Recent changes to the Australian Medicare Benefits Scheme have introduced the NOSE Score as a criteria threshold for funding rhinoplasty. On review of the literature, however, there is minimal normative Nasal Obstruction Symptom Evaluation (NOSE) score data to provide context for these changes. Participants were recruited according to the general Australian population distribution of age (18-65 years), gender and geographical locations using the market research company Pureprofile. The data included demographic details, risk factors for nasal obstruction such as smoking, obstructive sleep apnoea, use of continuous positive airway pressure, history of nasal trauma, operations to the nose and a history of cleft lip/palate and each participant completed the NOSE Scale. Analysis of data included descriptive statistics, independent t-tests and one-way analysis of variances to assess differences in NOSE scores between risk factors. The NOSE score was completed by 247 males and 255 females with a mean age of 41(±13.39) years. The cohort had a mean NOSE score of 16 (±18.89) with a range from 0 to 95. A total of 48 respondents had a NOSE score greater than the Medicare threshold of >45. Cleft lip/palate, obstructive sleep apnoea and continuous positive airway pressure use were shown to have a statistically significant impact on NOSE score while other variables including body mass index, gender, smoking, location and other surgery to the nose were not shown to significantly impact results. This study found that 9.6% of the general Australian population would have a NOSE score >45 and qualify for the Medicare Benefits Scheme rhinoplasty benefit.
Sections du résumé
BACKGROUND
Recent changes to the Australian Medicare Benefits Scheme have introduced the NOSE Score as a criteria threshold for funding rhinoplasty. On review of the literature, however, there is minimal normative Nasal Obstruction Symptom Evaluation (NOSE) score data to provide context for these changes.
METHODS
Participants were recruited according to the general Australian population distribution of age (18-65 years), gender and geographical locations using the market research company Pureprofile. The data included demographic details, risk factors for nasal obstruction such as smoking, obstructive sleep apnoea, use of continuous positive airway pressure, history of nasal trauma, operations to the nose and a history of cleft lip/palate and each participant completed the NOSE Scale. Analysis of data included descriptive statistics, independent t-tests and one-way analysis of variances to assess differences in NOSE scores between risk factors.
RESULTS
The NOSE score was completed by 247 males and 255 females with a mean age of 41(±13.39) years. The cohort had a mean NOSE score of 16 (±18.89) with a range from 0 to 95. A total of 48 respondents had a NOSE score greater than the Medicare threshold of >45. Cleft lip/palate, obstructive sleep apnoea and continuous positive airway pressure use were shown to have a statistically significant impact on NOSE score while other variables including body mass index, gender, smoking, location and other surgery to the nose were not shown to significantly impact results.
CONCLUSIONS
This study found that 9.6% of the general Australian population would have a NOSE score >45 and qualify for the Medicare Benefits Scheme rhinoplasty benefit.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2304-2309Informations de copyright
© 2020 Royal Australasian College of Surgeons.
Références
Friedman O, Cekic E, Gunel C. Functional rhinoplasty. Facial Plast. Surg. Clin. North Am. 2017; 25: 195-9.
Cannon DE, Rhee JS. Evidence-based practice: functional rhinoplasty. Otolaryngol. Clin. North Am. 2012; 45: 1033-43.
Pearson A, Wiechula R, Jordan Z, Henstridge V. Policy related to rhinoplasty in publicly funded elective surgery programs: a systematic review. Int. J. Evid. Based Healthc. 2009; 7: 94-111.
Hsu DW, Suh JD. Anatomy and physiology of nasal obstruction. Otolaryngol. Clin. North Am. 2018; 51: 853-65.
Australian Government Department of Health. Medicare Benefits Schedule Book Category 3. Canberra: Australian Government Department of Health. 2019 [Updated 1 November 2019; Cited 11November 2019.] Available from URL: http://www.health.gov.au/mbsonline
Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol. Head Neck Surg. 2004; 130: 157-63.
Barone M, Cogliandro A, Di Stefano N, Tambone V, Persichetti P. A systematic review of patient-reported outcome measures after rhinoplasty. Eur. Arch. Otorhinolaryngol. 2017; 274: 1807-11.
Stewart MG, Smith TL, Weaver EM et al. Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol. Head Neck Surg. 2004; 130: 283-90.
Gerecci D, Casanueva FJ, Mace JC et al. Nasal obstruction symptom evaluation score outcomes after septorhinoplasty. Laryngoscope 2018; 129: 841-846.
van Zijl F, Mokkink LB, Haagsma JA, Datema FR. Evaluation of measurement properties of patient-reported outcome measures after rhinoplasty: a systematic review. JAMA Facial Plast. Surg. 2019; 21: 152-162.
Lipan MJ, Most SP. Development of a severity classification system for subjective nasal obstruction. JAMA Facial Plast. Surg. 2013; 15: 358-61.
van Zijl F, Timman R, Datema FR. Adaptation and validation of the Dutch version of the nasal obstruction symptom evaluation (NOSE) scale. Eur. Arch. Otorhinolaryngol. 2017; 274: 2469-76.
Rhee JS, Sullivan CD, Frank DO, Kimbell JS, Garcia GJ. A systematic review of patient-reported nasal obstruction scores: defining normative and symptomatic ranges in surgical patients. JAMA Facial Plast. Surg. 2014; 16: 219-25.
Ishii L, Godoy A, Ishman SL, Gourin CG, Ishii M. The nasal obstruction symptom evaluation survey as a screening tool for obstructive sleep apnea. Arch. Otolaryngol. Head Neck Surg. 2011; 137: 119-23.
Lam DJ, James KT, Weaver EM. Comparison of anatomic, physiological, and subjective measures of the nasal airway. Am. J. Rhinol. 2006; 20: 463-70.
Georgalas C. The role of the nose in snoring and obstructive sleep apnoea: an update. Eur. Arch. Otorhinolaryngol. 2011; 268: 1365-73.
Australian Bureau of Statistics. Census of Population and Housing: Australia Revealed. Canberra: Australian Bureau of Statistics, 2016. [Updated 1 September 2017; Cited 9 December 2019.] Available from URL: https://www.abs.gov.au/ausstats/abs@.nsf/mf/2024.0.
Ross EE, Anari S. Clinical commissioning group criteria for rhinoplasty and septorhinoplasty in England: survey of current guidance. J. Laryngol. Otol. 2018; 132: 591-5.
Royal College of Surgeons of England. Is Access to Surgery a Postcode Lottery? London: Royal College of Surgeons of England. 2014. [Updated July 2014; Cited 13 February 2020.] Available from URL: http://www.rcseng.ac.uk/media/files/rcs/news_and_events/is_access_to_surgery_a_postcode_lottery.pdf.
Australian Bureau of Statistics. 4364.0.55.001 - National Health Survey: First Results, 2014-15. Canberra: Australian Bureau of Statistics. 2018. [Updated 11 December 2018; Cited 9 December 2019.] Available from URL: https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4364.0.55.001~2014-15~Main%20Features~Key%20findings~1.
Ulkumen B, Ulkumen BA, Pala HG et al. Pregnancy rhinitis in Turkish women: do gestational week, BMI and parity affect nasal congestion? Pak. J. Med. Sci. 2016; 32: 950-4.
Kanagalingam S, Shehab SS, Kaminsky DA, Wise RA, Lang JE, Dixon AE. Effect of obesity on sinonasal disease in asthma. J. Asthma 2018; 55: 525-31.
Steele TO, Mace JC, DeConde AS et al. Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery? Int. Forum Allergy Rhinol. 2015; 5: 1085-94.
Hens G, Vanaudenaerde BM, Bullens DM et al. Sinonasal pathology in nonallergic asthma and COPD: ‘united airway disease’ beyond the scope of allergy. Allergy 2008; 63: 261-7.
Roberts NJ, Lloyd-Owen SJ, Rapado F et al. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir. Med. 2003; 97: 909-14.
Uhliarova B, Adamkov M, Svec M, Calkovska A. The effect of smoking on CT score, bacterial colonization and distribution of inflammatory cells in the upper airways of patients with chronic rhinosinusitis. Inhal. Toxicol. 2014; 26: 419-25.
Ng CD. Errors in body mass index from self-reported data by sex and across waves of Add Health. Ann. Epidemiol. 2019; 39: 21-5.